Alliqua BioMedical Inc (ALQA)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alliqua BioMedical Inc (ALQA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011879
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial protection, and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. Alliqua BioMedical is headquartered in Yardley, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alliqua Enters Into Distribution Agreement With Sorbion 11
Licensing Agreements 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 14
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15
Equity Offering 16
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 16
Alliqua Completes Private Placement Of Shares For US$15 Million 17
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 18
Alliqua Completes Private Placement Of Shares For US$0.4 Million 19
Alliqua BioMedical Inc – Key Competitors 20
Alliqua BioMedical Inc – Key Employees 21
Alliqua BioMedical Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 23
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 26
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 27
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 28
Nov 04, 2016: Alliqua BioMedical Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results 31
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue 33
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th 34
Aug 09, 2016: Alliqua BioMedical Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results 35
Jul 07, 2016: Alliqua BioMedical Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue 37
May 10, 2016: Alliqua BioMedical Reports First Quarter Financial Results 38
Feb 23, 2016: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2015 Financial Results 40
Corporate Communications 42
Feb 19, 2016: Alliqua BioMedical Announces Changes to Its Board of Directors 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alliqua Enters Into Distribution Agreement With Sorbion 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 14
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 16
Alliqua Completes Private Placement Of Shares For US$15 Million 17
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 18
Alliqua Completes Private Placement Of Shares For US$0.4 Million 19
Alliqua BioMedical Inc, Key Competitors 20
Alliqua BioMedical Inc, Key Employees 21
Alliqua BioMedical Inc, Subsidiaries 22

★海外企業調査レポート[Alliqua BioMedical Inc (ALQA)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • A.G.Barr p.l.c.:企業の戦略・SWOT・財務情報
    A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report Summary A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • mBio Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary MBio Diagnostics Inc (MBio) is a medical device company that provides clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from …
  • DCP Midstream LP (DCP):石油・ガス:M&Aディール及び事業提携情報
    Summary DCP Midstream LP (DCP), formerly DCP Midstream Partners, LP, is a midstream energy company. It gathers, compresses, treats, and processes natural gas; and produces and markets natural gas liquids (NGL). The company also fractionates NGLs, and recovers and sells condensate. DCP transports NGL …
  • Euro India Fresh Foods, Ltd. (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods, Ltd. (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • E. & J. Gallo Winery:企業の戦略・SWOT・財務情報
    E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report Summary E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • Cosmo Films Ltd:戦略・SWOT・企業財務分析
    Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Citic Resources Holdings Limited
    Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …
  • Terumo Corp (4543):企業の製品パイプライン分析2018
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • Faron Pharmaceuticals Oy (FARN):製薬・医療:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • Ingram Entertainment Inc.:企業の戦略・SWOT・財務分析
    Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Beautiful Brands International, LLC:企業の戦略・SWOT・財務分析
    Beautiful Brands International, LLC - Strategy, SWOT and Corporate Finance Report Summary Beautiful Brands International, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Graham Group Ltd:企業の戦略・SWOT・財務情報
    Graham Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Graham Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Asiana Airlines Inc.:企業の戦略・SWOT・財務分析
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Toshiba Corporation:企業の戦略・SWOT・財務情報
    Toshiba Corporation - Strategy, SWOT and Corporate Finance Report Summary Toshiba Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Meggitt Plc (MGGT):企業の財務・戦略的SWOT分析
    Meggitt Plc (MGGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Securities Trust of Scotland plc (STS):企業の財務・戦略的SWOT分析
    Summary Securities Trust of Scotland plc (Securities Trust of Scotland) is a financial service provider that offers capital asset services, broking services, online stock broking services, and online dealing. The company raises income and long term capital growth through investment in a portfolio of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆